Dow Jones

44,860.31

0.28%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Synta Pharmaceuticals Corp. (MM) (SNTA)
Synta Pharmaceuticals Corp. (MM) (SNTA) Noticias

SNTA

Synta Pharmaceuticals Corp. (MM) (SNTA)

Synta Pharmaceuticals Corp. (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNTA

1 2 3 4 5 6 7 8 9 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
29/07/2016	14:13	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
26/07/2016	16:56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
26/07/2016	14:38	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
22/07/2016	16:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
22/07/2016	10:30	GlobeNewswire Inc.	Madrigal Pharmaceuticals Completes Merger with Synta to Create Leading Cardiovascular-Metabolic Diseases and NASH Company	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
21/07/2016	15:17	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
20/07/2016	15:04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
06/07/2016	15:28	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
01/07/2016	06:35	PR Newswire (US)	Why Investors Have These Biotech Stocks on Their Radar? - Synta Pharma, Idera Pharma, Threshold Pharma, and Viking Therapeuti...	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
08/06/2016	15:15	Business Wire	Synta Announces Date and Location of Annual Meeting of Stockholders to Vote on Merger with Madrigal Pharmaceuticals	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
08/06/2016	15:03	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
02/06/2016	06:00	Business Wire	Synta Pharmaceuticals to Present at Upcoming Investor Conferences in June	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
27/05/2016	07:20	PR Newswire (US)	Why Biotech Stocks Fascinate Investors? - Synta Pharma, CTI BioPharma, Lpath, and Heat Biologics	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
19/05/2016	05:03	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (preliminary) (prem14a)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
29/04/2016	07:33	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
28/04/2016	05:12	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
14/04/2016	06:00	Business Wire	Synta and Madrigal Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and NASH Company	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
13/11/2015	10:22	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
05/11/2015	16:20	Business Wire	Synta Reports Third Quarter 2015 Financial Results	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
20/10/2015	18:30	Business Wire	Synta Announces Termination for Futility of Ganetespib Phase 3 GALAXY-2 Trial in Lung Cancer	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
08/10/2015	06:30	Business Wire	Synta Pharmaceuticals Announces Formation of Expert Oncology Panel	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
09/09/2015	07:00	Business Wire	Synta Names Alan C. Rigby, Ph.D. Chief Scientific Officer	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
08/09/2015	07:00	Business Wire	Synta Announces Presentations at the 16th Annual World Conference on Lung Cancer	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
02/09/2015	15:01	Business Wire	Synta to Participate in FBR Second Annual Healthcare Conference	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
06/08/2015	11:08	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
06/08/2015	06:00	Business Wire	Synta Reports Second Quarter 2015 Financial Results	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
30/07/2015	15:01	Business Wire	Synta to Host Conference Call and Webcast of Second Quarter 2015 Financial Results on August 6, 2015	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
23/06/2015	07:00	Business Wire	Synta Announces Journal Publication Describing Complementary Activity of Hsp90 Inhibition & Immune Checkpoint Blockade for Ca...	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
16/06/2015	15:01	Business Wire	Synta to Participate in Upcoming Investor Conferences	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
02/06/2015	08:00	Business Wire	Synta Announces Ganetespib Program Updates	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)